Factive
Active Ingredient(s): GemifloxacinFDA Approved: * April 4, 2003
Pharm Company: * OSCIENT
Category: Antibiotics
Gemifloxacin mesylate (trade name Factive, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. Vansen Pharma Inc. has licensed the active ingredient from LG Life Sciences of Korea. Contents 1 Indications 2 Microbiology 3 Adverse effects 4 Current findings 5 See also 6 References Indications Gemifloxacin is indicated for the treatment of infections ca... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Popular Topics
factive320mg
pharengeal problems...